Symphony Financial’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-857
Closed -$255K 373
2026
Q1
$255K Buy
+857
New +$255K 0.03% 263
2025
Q3
Sell
-1,925
Closed -$232K 276
2025
Q2
$232K Buy
+1,925
New +$523K 0.03% 232
2024
Q4
Sell
-1,122
Closed -$245K 226
2024
Q3
$245K Sell
1,122
-3,703
-77% -$766K 0.04% 197
2024
Q2
$946K Buy
4,825
+3,876
+408% +$801K 0.17% 100
2024
Q1
$204K Sell
949
-3,054
-76% -$642K 0.05% 184
2023
Q4
$796K Buy
+4,003
New +$854K 0.17% 102
2020
Q3
Sell
-1,737
Closed -$282K 142
2020
Q2
$282K Buy
+1,737
New +$311K 0.14% 111

Other funds holding CME

Symphony Financial's CME Position: Q2 2026 in Review

Symphony Financial sold out of CME Group (CME) in Q2 2026, closing a stake of 857 shares — an estimated $255K sold.

Symphony Financial first reported a position in CME in Q2 2020 and held it in 7 quarters. The position peaked at $946K in Q2 2024. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Symphony Financial reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Symphony Financial sold 857 CME Group shares in Q2 2026, an estimated $255K.
  • Symphony Financial first reported a position in CME Group in Q2 2020 and held it in 7 quarters.
  • Symphony Financial's CME Group position peaked at $946K in Q2 2024.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Symphony Financial's 13F filing for Q2 2026, filed 4 Aug 2026.